Loading...
XNAS
RKDA
Market cap1mUSD
Jul 09, Last price  
0.68USD
1D
-1.14%
1Q
-48.83%
Jan 2017
-99.91%
IPO
-99.99%
Name

Arcadia Biosciences Inc

Chart & Performance

D1W1MN
XNAS:RKDA chart
P/E
—
P/S
0.22
EPS
—
Div Yield, %
—
Shrs. gr., 5y
40.60%
Rev. gr., 5y
-9.57%
Revenues
5m
-3.71%
7,010,0006,478,0006,982,0005,414,0003,188,0004,026,0001,464,0001,169,0008,034,0006,780,0007,418,0004,454,0005,045,0004,858,000
Net income
-2m
L-66.77%
-12,370,000-13,195,000-18,339,000-17,956,000-19,624,000-15,707,000-13,480,000-28,805,000-4,655,000-14,660,000-15,376,000-13,981,000-7,038,000-2,339,000
CFO
-5m
L-50.77%
-9,588,000-9,745,000-14,787,000-15,109,000-17,055,000-13,965,000-13,631,000-17,198,000-30,218,000-25,868,000-13,977,000-15,294,000-9,627,000-4,739,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
URL
https://arcadiabio.com/
IPO date
May 15, 2015
Employees
30
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT